Oncolytic virotherapy for the treatment of Non-Hodgkin Lymphoma
Non-Hodgkin Lymphoma (NHL) is a diverse group of more than 80 predominantly B cell cancers of the lymphatic system. Poor survival rates in aggressive subsets, the transformation of indolent subsets into aggressive forms, and the emergence of therapy-resistance warrants research into novel therapies....
| Main Author: | |
|---|---|
| Other Authors: | |
| Published: |
University of Leeds
2018
|
| Online Access: | https://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.759801 |